| # | Drug | Count |
|---|---|---|
| 0 | ACETAZOLAMIDE | 17 |
| 1 | ACETAZOLAMIDE SODIUM | 17 |
| 2 | BRIMONIDINE TARTRATE | 12 |
| 3 | BRIMONIDINE | 9 |
| 4 | LATANOPROST | 7 |
| 5 | TIMOLOL | 7 |
| 6 | GABAPENTIN | 5 |
| 7 | PREDNISONE | 5 |
| 8 | ADALIMUMAB | 4 |
| 9 | ADALIMUMAB-AATY | 4 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PILOCARPINE HYDROCHLORIDE OPHTHALMIC SOLUTION | 4 | 0.0033 |
| 1 | ACETAZOLAMIDE SODIUM | 17 | 0.0028 |
| 2 | PILOCARPINE HYDROCHLORIDE | 4 | 0.0016 |
| 3 | MITOMYCIN | 3 | 0.0008 |
| 4 | MANNITOL | 4 | 0.0008 |
| 5 | BRIMONIDINE TARTRATE | 12 | 0.0007 |
| 6 | INFLIXIMAB-DYYB | 2 | 0.0006 |
| 7 | TIMOLOL | 7 | 0.0006 |
| 8 | NETARSUDIL | 1 | 0.0005 |
| 9 | DORZOLAMIDE | 3 | 0.0004 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Carbonic Anhydrase Inhibitor [EPC] | 17 | 0.0008 |
| 1 | Osmotic Diuretic [EPC] | 4 | 0.0008 |
| 2 | Prostaglandin Analog [EPC] | 7 | 0.0001 |
| 3 | CTLA-4-directed Blocking Antibody [EPC] | 2 | 0.0000 |
| 4 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 5 | 0.0000 |
| 5 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 2 | 0.0000 |
| 6 | Alkylating Drug [EPC] | 3 | 0.0000 |
| 7 | Corticosteroid [EPC] | 6 | 0.0000 |
| 8 | Tumor Necrosis Factor Blocker [EPC] | 4 | 0.0000 |
| 9 | Vitamin D [EPC] | 1 | 0.0000 |